Atenolol Market Analysis

  • Report ID: 4076
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Atenolol Market Analysis

Application (Hypertension, Angina, Arrhythmia)

The global atenolol market is segmented and analyzed for demand and supply by application into hypertension, angina, arrhythmia, and others. Out of these four types of segments, the hypertension segment is estimated to gain the largest market share of about 55% in the year 2037. The growth of the segment can be attributed to the increasing prevalence of hypertension throughout the world, coupled with the expanding demand and consumption of antihypertensive drugs across the globe. For instance, the worldwide revenue of antihypertensive drugs is anticipated to boost by around USD 24 billion by the end of 2023. In addition to this, the rising awareness in people regarding hypertension is also estimated to fuel the segment growth in the coming years.

Distribution Channel (Hospital Pharmacies, Drug Stores, Online Pharmacies)

The global atenolol market is also segmented and analyzed for demand and supply by distribution channel into hospital pharmacies, drug stores, online pharmacies, and others. Amongst these four segments, the hospital pharmacies segment is expected to garner a significant share of around 49% in the year 2037. The growth of the segment can be attributed to the rising patient pool of hypertension, arrhythmia, angina, and so on in hospitals to get better treatment, coupled with the surging ratio of hospitals throughout the world. In addition to this, the rise in cardiovascular disorder is also anticipated to accelerate segment growth in the coming years. On the other hand, the online pharmacies segment is projected to witness an impressive CAGR during the forecast period on the back of the rising awareness of these online platforms amongst users worldwide. In addition to this, the expanding penetration of the internet throughout the world is another major factor estimated to drive segment growth across the globe in the coming years.

Our in-depth analysis of the global market includes the following segments:

         By Form

  • Tablets
  • IV Solution
  • Others

        By Dosage Type

  • 25 mg
  • 50 mg
  • 100 mg

       By Application

  • Hypertension
  • Angina
  • Arrhythmia
  • Others

      By Distribution Channel

  • Hospital Pharmacies
  • Drug Stores
  • Online Pharmacies
  • Others
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4076
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of atenolol is assessed at USD 13.33 billion.

The atenolol market size was over USD 12.23 billion in 2024 and is anticipated to cross USD 24.53 billion by 2037, witnessing more than 5.5% CAGR during the forecast period i.e., between 2025-2037. Growing prevalence of angina experiences, expansion in sedentary lifestyle, and increasing prevalence of arrhythmia will boost the market growth.

North America industry is set to hold largest revenue share of 40% by 2037, attributed to increasing prevalence of cardiac diseases, along with rising frequency of hypertension in the region.

The major players in the market are Intas Pharmaceuticals Limited, Abbott Laboratories, F. Hoffmann-La Roche Ltd, Danaher Corporation, Bio-Rad Laboratories, Inc., Sysmex Corporation, Zydus Pharmaceuticals (USA) Inc., Ipca Laboratories Limited, Unichem Laboratories Limited, AstraZeneca PLC
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample